Skip to Main Content

Author Details

David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
1983
313
89
PMIDPaper TitleJournal TitlePublished Year
36862513A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis.J Clin Invest2023
37344597B-cell-specific checkpoint molecules that regulate anti-tumour immunity.Nature2023
36834954The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors.Int J Mol Sci2023
36588115A unique hyperdynamic dimer interface permits small molecule perturbation of the melanoma oncoprotein MITF for melanoma therapy.Cell Res2023
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
37019082NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.Cell Metab2023
37198474Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions.Nat Metab2023
36634707Targeting TBK1 to overcome resistance to cancer immunotherapy.Nature2023
37256936Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas.Sci Transl Med2023
37063845mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic.Front Immunol2023
36745048Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.Cancer Discov2023
36862513A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis.J Clin Invest2023
37256936Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas.Sci Transl Med2023
37019082NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.Cell Metab2023
37344597B-cell-specific checkpoint molecules that regulate anti-tumour immunity.Nature2023
37198474Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions.Nat Metab2023
37063845mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic.Front Immunol2023
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
36588115A unique hyperdynamic dimer interface permits small molecule perturbation of the melanoma oncoprotein MITF for melanoma therapy.Cell Res2023
36745048Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.Cancer Discov2023
36834954The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors.Int J Mol Sci2023
36634707Targeting TBK1 to overcome resistance to cancer immunotherapy.Nature2023
35131084Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma.J Invest Dermatol2022
35561684Topical therapy for regression and melanoma prevention of congenital giant nevi.Cell2022
36525492β-Endorphin mediates radiation therapy fatigue.Sci Adv2022
35131084Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma.J Invest Dermatol2022
35561684Topical therapy for regression and melanoma prevention of congenital giant nevi.Cell2022
36525492β-Endorphin mediates radiation therapy fatigue.Sci Adv2022
32268150Treatment of Advanced Melanoma in 2020 and Beyond.J Invest Dermatol2021
35663368The role of MiT/TFE family members in autophagy regulation.Curr Top Biochem Res2021
32268150Treatment of Advanced Melanoma in 2020 and Beyond.J Invest Dermatol2021
33811065Reduced MC4R signaling alters nociceptive thresholds associated with red hair.Sci Adv2021
34233163NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism.Cell2021
34117054Vitamin D deficiency exacerbates UV/endorphin and opioid addiction.Sci Adv2021
33794192CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolism.Cell Chem Biol2021
33504438The Melanocyte Lineage Factor miR-211 Promotes BRAF<sup>V600E</sup> Inhibitor Resistance.J Invest Dermatol2021
33759772Biology of Melanoma.Hematol Oncol Clin North Am2021
33598985Stress-associated ectopic differentiation of melanocyte stem cells and ORS amelanotic melanocytes in an ex vivo human hair follicle model.Exp Dermatol2021
33597266Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses.Sci Transl Med2021
33320376Skin pigmentation and its control: From ultraviolet radiation to stem cells.Exp Dermatol2021
33414132The State of Melanoma: Emergent Challenges and Opportunities.Clin Cancer Res2021
33382172Melanocortin 1 receptor is dispensable for acute stress induced hair graying in mice.Exp Dermatol2021
34565559MFN2 Stabilization: A Bridge for Endoplasmic Reticulum Stress Sensitivity in Melanoma.J Invest Dermatol2021
34728538SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis.Cancer Res2021
34956734Commentary on NNT Mediates Redox-Dependent Pigmentation <i>via</i> a UVB-And MITF-Independent Mechanism.J Cell Sci Ther2021
34691767G9a: An Emerging Epigenetic Target for Melanoma Therapy.Epigenomes2021
35663368The role of MiT/TFE family members in autophagy regulation.Curr Top Biochem Res2021
33794192CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolism.Cell Chem Biol2021
33598985Stress-associated ectopic differentiation of melanocyte stem cells and ORS amelanotic melanocytes in an ex vivo human hair follicle model.Exp Dermatol2021
33597266Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses.Sci Transl Med2021
  • 1 - 50 of 626

Recommended Authors

The University of Manchester
Career Start Year 2015
Number of shared co-authors 14
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 1
Thomas Jefferson University
Career Start Year 2011
Number of shared co-authors 5
National Cancer Institute, National Institutes of Health
Career Start Year 2010
Number of shared co-authors 9
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 8
Institut National de la Sante et de la Recherche Medicale (INSERM) U
Career Start Year 2010
Number of shared co-authors 7
Institute of Anatomy, University of Zurich
Career Start Year 2009
Number of shared co-authors 16
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 28
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 2008
Number of shared co-authors 12
University Hospital of Zurich
Career Start Year 2007
Number of shared co-authors 21
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 7
National Center for Toxicological Research
Career Start Year 2006
Number of shared co-authors 4
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2002
Number of shared co-authors 13
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 15
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 9
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 7
Max Planck Institute of Molecular Cell Biology and Genetics
Career Start Year 2001
Number of shared co-authors 0
National Cancer Institute
Career Start Year 2000
Number of shared co-authors 9
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 9
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 16
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 9
University of Maryland School of Medicine
Career Start Year 1989
Number of shared co-authors 6
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 13
Stanford University
Career Start Year 1985
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 4
Inc. 30301 Agoura Rd.
Career Start Year 1979
Number of shared co-authors 2
National Cancer Institute
Career Start Year 1976
Number of shared co-authors 18
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 12

Collaborators

Co-authored papers 12
University of Illinois at Urbana-Champaign
Co-authored papers 11
Broad Institute of Harvard and MIT
Co-authored papers 10
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 9
Yale School of Medicine
Co-authored papers 6
Co-authored papers 6
UPMC Hillman Cancer Center
Co-authored papers 5
Co-authored papers 5
Broad Institute
Co-authored papers 4
Co-authored papers 4
Harvard TH Chan School of Public Health
Co-authored papers 4
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
BioMedical Center, University of Iceland
Co-authored papers 4
Co-authored papers 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 4
University of Bern
Co-authored papers 4
Broad Institute of MIT and Harvard
Co-authored papers 4
Co-authored papers 4
Dana Farber Cancer Institute/Boston Children's Hospital
Co-authored papers 3
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University
Co-authored papers 3
Harvard University
Co-authored papers 3
Saint John's Cancer Institute at Saint John's Health Center
Co-authored papers 3
Co-authored papers 3
Yale University School of Medicine
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
Broad Institute of MIT and Harvard
Co-authored papers 3
Institut Curie, PSL Research University, INSERM U1021
Co-authored papers 3